Skip to content

Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients

Surgery Versus Laser Ablation of Anal Diseases in Inflammatory Bowel Disease Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06216223
Enrollment
108
Registered
2024-01-22
Start date
2023-09-05
Completion date
2024-04-05
Last updated
2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal Fissure, Hemorrhoids, Inflammatory Bowel Diseases

Keywords

anal fissure, hemorrhoids, inflammatory bowel disease, crohn's disease, ulcerative colitis

Brief summary

This is a randomized comparative clinical trial carried out to compare between laser ablation and surgery in treating anal diseases in inflammatory bowel diseases patients and find out if one is superior to the other. Inflammatory bowel diseases patients with anal problems were divided into 2 groups, one group had traditional surgery and the other had laser ablation for anal diseases and results were compared between the 2 groups.

Interventions

PROCEDUREtreatment of anal diseases in inflammatory bowel patients

treatment of anal diseases in inflammatory bowel patients

DEVICELaser

laser

traditional surgery

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients with history of inflammatory bowel disease ( non specific colitis, crohn's disease, ulcerative colitis). * Patients who accidently discovered to have inflammatory bowel disease. * Age group between 18 to 60 years old

Exclusion criteria

* Informed consent refusal. * Proved malignancy in inflammatory bowel disease patients * Patients less than 18 years old or more than 60 years old * Contraindications to general and spinal anesthesia * other types of colitis as ischemic colitis, pseudo-membranous colitis, infective colitis

Design outcomes

Primary

MeasureTime frameDescription
Discharge from hospitalfrom one day post operative to one weekhospital stay studied between the 2 groups
Recurrencedetection of recurrence from 3 to 6 months after operationrecurrence between 2 groups was assessed
Fistula occurencefrom 2 weeks to 2 months after operationfistula occurence studied between the 2 groups
Stenosisstenosis was detected from wound healing to 6 months laterpost operative stenosis between the 2 groups was studied
Operation timeIntraoperative (from skin incision to wound dressing.)operation time in minutes was studied between the 2 groups
operative bleedingIntraoperative to 2 weeks after operation.bleeding in cc was calculated between the 2 groups
post operative anal dischargefrom incision to 2 weeks after operation.presence of post operative anal discharge was detected in the 2 groups
pain score with visual analogue scalefrom the 1st day to 2 weeks postoperativelypain score with visual analogue scale was studied between the 2 groups,minimum score is 0 which means painless and maximum score is 10 which means very painful
Healing timehealing time was studies from the 1st day to 3 months after operationtime for complete healing after operation was studied between the 2 groups
Return to workReturn to work was assessed from one day to 2 months after surgeryReturn to work after operation was studied between the 2 groups
patient satisfaction scorefrom one day to 3 months after operationpatient satisfaction score among patients in the 2 groups was studied using customer satisfaction score, minimum score is 1 means very dissatisfied and maximum score is 10 means very satisfied

Secondary

MeasureTime frameDescription
sexsex of participants was recorded for one year duration of the studysex was studied in the 2 groups
specific diseasediagnosis of diseases known 2 days before surgery from historydiagnosis of crohn's disease, ulcerative colitis, non specific colitis by colonoscopy and biopsy was done in the 2 groups
ageage of participants was recorded for one year duration of the studyage in the 2 groups was studied

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026